Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy

Open Access

Peer-reviewed

Research Article

Tilda Barliya ,

Contributed equally to this work with: Tilda Barliya, Mathilda Mandel

Affiliation The Blood Center, Sheba Medical Center, Ramat-Gan, Israel
⨯
Mathilda Mandel ,

Contributed equally to this work with: Tilda Barliya, Mathilda Mandel

Affiliation The Blood Center, Sheba Medical Center, Ramat-Gan, Israel
⨯
Tami Livnat,

Affiliation Institute of Hematology, Sheba Medical Center, Ramat-Gan, Israel
⨯
Dov Weinberger,

Affiliations Department of Ophthalmology, Beilinson Medical Center, Petah-Tiqva, Israel, Department of Ophthalmology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⨯
Gad Lavie

* E-mail: gad.lavie@sheba.health.gov.il

Affiliations The Blood Center, Sheba Medical Center, Ramat-Gan, Israel, Department of Cellular and Developmental Biology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
⨯

Reader Comments (0)

Hypoxia
Is the Subject Area "Hypoxia" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
DNA transcription
Is the Subject Area "DNA transcription" applicable to this article?

Thanks for your feedback.
Proteasomes
Is the Subject Area "Proteasomes" applicable to this article?

Thanks for your feedback.